Skip to main content

Client News

Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study

3rd September 2020

Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020

24th August 2020

Adrenomed AG: Targeting endothelial barrier function in critically ill COVID-19 patients: Adrecizumab shows beneficial effects

24th August 2020

CENTOGENE AG: CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

20th August 2020

Verona Pharma plc Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD

19th August 2020

dievini Hopp BioTech holding GmbH Congratulates CureVac on Successful Nasdaq IPO

19th August 2020

CENTOGENE AG: CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport

19th August 2020

Adocia was granted a State-guaranteed loan (PGE) for EUR 7 million associated with a rescheduling of loan terms contracted in 2019

18th August 2020

4basebio AG announces process for spin-off and separate stock market listing for its DNA business

17th August 2020

AiCuris launches “PREP – Pandemic and Resistance Emergency Preparedness” program at upcoming 4th AMR Conference

17th August 2020